Aurora Cannabis And Willow Biosciences Resolve Patent Clash
Aurora Cannabis And Willow Biosciences Resolve Patent Clash
Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced Tuesday that it had successfully completed a confidential settlement resolving an ongoing patent litigation with Willow Biosciences Inc. (OTCQB:CANSF) (TSX:WLLW).
奧羅拉大麻公司。納斯達克股票代碼：ACB)(多倫多證券交易所股票代碼：ACB)週二宣佈成功完成了一項保密和解解決了一起正在進行的專利訴訟柳樹生物科學公司。(OTCQB：CANSF)(多倫多證券交易所：WLLW)。
Aurora undertook the patent infringement action in July 2021, alleging that Willow's biosynthetic process for synthesizing cannabinoids infringed Aurora's exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council (NRC).
Aurora於2021年7月提起專利侵權訴訟，聲稱Willow合成大麻類化合物的生物合成工藝侵犯了Aurora對薩斯喀徹溫省大學和國家研究委員會(NRC)。
The technology of the asserted patents was invented by Anandia co-founder and former chief science officer at Aurora, Jonathan Page and his colleagues, following their work at the University of Saskatchewan and the NRC. They identified key enzymes and corresponding genes in the biosynthetic pathways of cannabis plants.
這些專利的技術是由Anandia聯合創始人兼Aurora前首席科學官喬納森·佩奇和他的同事在薩斯喀徹溫省大學和NRC工作後發明的。他們確定了大麻植物生物合成途徑中的關鍵酵素和相應的基因。
In December 2022, Willow announced that it had consolidated its R&D operations, transferring equipment and key personnel from its Canadian facilities to Mountain View, California.
2022年12月，Willow宣佈整合了其研發業務，將設備和關鍵人員從加拿大設施轉移到加利福尼亞州山景城。
"We are pleased with the negotiated settlement, which provides Aurora a favorable resolution that ensures our Canadian cannabis-related patent rights are respected," Miguel Martin, CEO of Aurora said. "Aurora is a pioneer in terms of the company's genetics work in the Canadian cannabis industry and will not hesitate to continue to take the steps necessary, including legal action, to protect and enforce our intellectual property rights when necessary."
我們對通過談判達成的和解協定感到高興，它為奧羅拉提供了一個有利的解決方案，確保我們加拿大與大麻相關的專利權得到尊重。米格爾·馬丁，Aurora首席執行官表示。就該公司在加拿大大麻行業的遺傳學工作而言，Aurora是先驅，並將毫不猶豫地繼續採取必要的步驟，包括在必要時採取法律行動，以保護和執行我們的知識產權。
ACB Price Action
ACB價格行動
Aurora's shares traded 0.8728% higher at $0.4276 per share at the time of writing on Tuesday morning.
Did you miss the first wave of cannabis investments? Don't make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth. Join Benzinga PotProfits. Benefit from Michael Berger's sharp analysis, revealing top cannabis stock opportunities and timely updates. Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now, before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.
奧羅拉的股價上漲0.8728%，至每股0.4276美元。在我寫這篇文章的時候，是在週二上午。
你是否錯過了對第一波大麻投資的預期？別再犯同樣的錯誤了。
專家認為大麻庫存已經觸底現在正準備實現前所未有的增長。會合Benzinga PotProfits。受益於Michael Berger的敏銳分析，揭示了頂級大麻庫存機會並及時更新。在短短90天內體驗10%以上的潛在回報。我們對Marketfy的4.5星評級很能說明問題。在這個蓬勃發展的行業，通過30天的退款保證。現在就是投資的時候，在其他人都意識到之前。使用Benzinga確保您的利潤。立即單擊此處瞭解更多資訊。
Related News
相關新聞
- Aurora And Curaleaf Cannabis Companies Each Close Multi-Million Dollar Funding Deals
- Aurora Stock Plunges On $25M Bought Deal To Repay Convertible Debt
- Aurora Cannabis Launches New Brand At Toronto Hall of Flowers, This Is What Innovation Looks Like
- Aurora和Curaleaf大麻公司分別完成數百萬美元的融資交易
- Aurora股票以2500萬美元收購交易償還可轉換債務
- Aurora Cannabis在多倫多花卉大廳推出新品牌，這就是創新的樣子
Photo: Courtesy of succo, mrkukuruznik5 by Pixabay
圖片：由Succo提供，mrkukuruznik5由Pixabay提供